Fingerprint
Dive into the research topics of 'Corrigendum to “Entrectinib in patients with ROS1 fusion-positive non-small cell lung cancer (NSCLC) or NTRK fusion-positive solid tumours: Analysis of response by line of therapy” (Annals of Oncology (2020) 31(S4) (S472–S473), (S0923753420406507), (10.1016/j.annonc.2020.08.654))'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically